Icon

OPTIVAR (nda021127)- (0.05%)

AZELASTINE HYDROCHLORIDE MYLAN SPECIALITY LP
0.05%
Yes No
2011-May-01 Expired
None None
None No
OPTIVARĀ® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
7 0 6
Total Other Developers None
Drugs with Suitability No
0.05% ** ** - 6 -
NDA Sales Available Total Generic Sales Available
No 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ****** ***** ******** *** *********** **** ***** *******, **** *****, ***** (**) *****, ****** ****** (***) ***
****** ******** ******* *** ******** ************ ******* *********** **/*, ******** ******* *********** *****, *********, ********* ******, ***** (***) ***
****** ******* ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.